• 1
    Boyle P, Severi G, Giles GG. The epidemiology of prostate cancer. Urol Clin North Am 2003; 30: 20917
  • 2
    Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 76581
  • 3
    Inghelmann R, Grande E, Francisci S et al. Regional estimates of prostate cancer burden in Italy. Tumori 2007; 93: 3806
  • 4
    Quaglia A, Parodi S, Grosclaude P, Martinez-Garcia C, Coebergh JW, Vercelli M. Differences in the epidemic rise and decrease of prostate cancer among geographical areas in Southern Europe. an analysis of differential trends in incidence and mortality in France, Italy and Spain. Eur J Cancer 2003; 39: 6545
  • 5
    Gatta G, Zigon G, Buemi A et al. Prostate cancer treatment in Europe at the end of 1990s. Acta Oncol 2009; 48: 86773
  • 6
    GLOBOCAN. GLOBOCAN 2008 Report of the International Agency for Research on Cancer. 2008. Available at: Accessed January 2012
  • 7
    Mohler J, Bahnson RR, Boston B et al. NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 2010; 8: 162200
  • 8
    Heidenreich A, Bellmunt J, Bolla M et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011; 59: 6171
  • 9
    Mottet N, Bellmunt J, Bolla M et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011; 59: 57283
  • 10
    Thompson I, Thrasher JB, Aus G et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007; 177: 210631
  • 11
    Klotz L. Active surveillance for prostate cancer: a review. Curr Urol Rep 2010; 11: 16571
  • 12
    van den Bergh RC, Vasarainen H, van der Poel HG et al. Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study. BJU Int 2010; 105: 95662
  • 13
    Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010; 76 (Suppl.): S1239
  • 14
    Roach M 3rd, Nam J, Gagliardi G, El Naqa I, Deasy JO, Marks LB. Radiation dose-volume effects and the penile bulb. Int J Radiat Oncol Biol Phys 2010; 76 (Suppl.): S1304
  • 15
    Valdagni R, Rancati T, Fiorino C et al. Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT. Int J Radiat Oncol Biol Phys 2008; 71: 106573
  • 16
    O'Rourke ME. Decision making and prostate cancer treatment selection: a review. Semin Oncol Nurs 2001; 17: 10817
  • 17
    Wong F, Stewart DE, Dancey J et al. Men with prostate cancer: influence of psychological factors on informational needs and decision making. J Psychosom Res 2000; 49: 139
  • 18
    Jang TL, Bekelman JE, Liu Y et al. Physician visits prior to treatment for clinically localized prostate cancer. Arch Intern Med 2010; 170: 44050
  • 19
    Weber BA, Sherwill-Navarro P. Psychosocial consequences of prostate cancer: 30 years of research. Geriatr Nurs 2005; 26: 16675
  • 20
    Fowler FJ Jr, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000; 283: 321722
  • 21
    Touijer K. Marketing versus science: a fight between necessary evil and stern good over the adoption of new technology in medicine. Eur Urol 2010; 58: 5224
  • 22
    Kagan AR. The multidisciplinary clinic. Int J Radiat Oncol Biol Phys 2005; 61: 9678
  • 23
    Ruhstaller T, Roe H, Thurlimann B, Nicoll JJ. The multidisciplinary meeting: an indispensable aid to communication between different specialities. Eur J Cancer 2006; 42: 245962
  • 24
    Fleissig A, Jenkins V, Catt S, Fallowfield L. Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol 2006; 7: 93543
  • 25
    Sidhom MA, Poulsen MG. Multidisciplinary care in oncology: medicolegal implications of group decisions. Lancet Oncol 2006; 7: 9514
  • 26
    Boyle FM, Robinson E, Dunn SM, Heinrich PC. Multidisciplinary care in cancer: the fellowship of the ring. J Clin Oncol 2005; 23: 91620
  • 27
    Ko C, Chaudhry S. The need for a multidisciplinary approach to cancer care. J Surg Res 2002; 105: 537
  • 28
    Valicenti RK, Gomella LG, El-Gabry EA et al. The multidisciplinary clinic approach to prostate cancer counseling and treatment. Semin Urol Oncol 2000; 18: 18891
  • 29
    Valdagni R, Salvioni R, Nicolai N et al. In regard to Kagan: ‘The multidisciplinary clinic’ (Int J Radiat Oncol Biol Phys 2005;61:967–968). Int J Radiat Oncol Biol Phys 2005; 63: 30910
  • 30
    Gomella LG, Lin J, Hoffman-Censits J et al. Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract 2010; 6: e510
  • 31
    Fitzpatrick JM, Anderson J, Sternberg CN et al. Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach. Crit Rev Oncol Hematol 2008; 68 (Suppl. 1): S922
  • 32
    Bellmunt J, Gelabert A. Medical management of advanced prostate cancer: a multidisciplinary team approach. Expert Rev Anticancer Ther 2007; 7: 9779
  • 33
    Basler JW, Jenkins C, Swanson G. Multidisciplinary management of prostate malignancy. Curr Urol Rep 2005; 6: 22834
  • 34
    Carducci MA, Carroll PR. Multidisciplinary management of advanced prostate cancer: changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials. Urology 2005; 65 (Suppl.): 1822
  • 35
    Hudak JL, McLeod DG, Brassell SA et al. The design and implementation sof a multidisciplinary prostate cancer clinic. Urol Nurs 2007; 27: 4918
  • 36
    Kurpad R, Kim W, Rathmell WK et al. A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions? Urol Oncol 2011; 29: 37882
  • 37
    Bellardita L, Donegani S, Spatuzzi AL, Valdagni R. Multidisciplinary versus one-on-one setting: a qualitative study of clinicians' perceptions of their relationship with patients with prostate cancer. J Oncol Pract 2011; 7: e15